Skip to content

Author

Qian Ding

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jan 2026

FAP as a Clinical Biomarker: FAP+ CAFs Orchestrate an Immunosuppressive Stem Cell Niche via the COL1A1/2‐CD44 Axis in Colon Cancer

This study demonstrates that FAP+ CAFs orchestrate a dual‐functional “immunosuppressive stem cell niche” via the COL1A1/2‐CD44 signaling axis and Targeting this FAP‐driven niche provides a promising strategy for overcoming immunotherapy resistance and improving clinical outcomes in CC.

Qian Ding, Qing-Yan Lu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.